Mesothelioma immunotherapy uses medicines that help the immune system recognize and attack cancer cells. For some people with pleural mesothelioma, it can slow cancer or shrink tumors, often as part of a plan shaped by cancer type, extent, overall health, and personal goals.
In Brief
- Immunotherapy helps the immune system respond to cancer. Checkpoint inhibitors are the main type used for mesothelioma.
- Some people with pleural mesothelioma may receive immunotherapy alone or with chemotherapy.
- Treatment can control cancer for some patients, but it does not work for everyone and can cause serious side effects.
- A cancer specialist can explain approved options, clinical trials, and how treatment fits with a person’s health and preferences.
What mesothelioma immunotherapy does
Immunotherapy is treatment that helps the body’s immune system find and attack cancer. The National Cancer Institute explains that some cancer cells evade immune defenses by using checkpoint signals, which normally help prevent the immune system from attacking healthy tissue.
Checkpoint inhibitors block certain signals, allowing immune cells to respond more strongly to cancer. Nivolumab and ipilimumab are checkpoint inhibitor medicines used together. Pembrolizumab is another checkpoint inhibitor that may be combined with chemotherapy. These medicines are not the same as chemotherapy, which directly damages rapidly growing cells.
In the United States, the FDA has approved these combinations for certain adults with unresectable pleural mesothelioma. Unresectable means surgery cannot remove the cancer. The options and approvals can differ by cancer type and individual circumstances, so a specialist should confirm what applies.
Who may receive immunotherapy for mesothelioma
Immunotherapy is most established for pleural mesothelioma, which begins in the lining around the lungs. Evidence and treatment options can differ for peritoneal mesothelioma, which begins in the lining of the abdomen. A person’s overall health, other medical conditions, previous treatments, and treatment goals also matter.
Doctors diagnose mesothelioma using a medical history, imaging tests, and usually a biopsy. A biopsy is a small tissue sample examined in a laboratory. Pathologists assess the sample to identify the cancer type, while scans help show where it has spread. A specialist may also review whether the cancer can be removed with surgery and which treatments are suitable.
Immunotherapy can be given on its own or with chemotherapy, depending on the treatment plan. Clinical trials may be an option when a person wants to consider a treatment still being studied. Ask the care team about the aim of treatment, expected visits, alternatives, and what happens if the cancer grows or side effects become difficult.
Benefits, limits, and possible side effects
Some people have tumors that shrink or stop growing for a time with immunotherapy. Others do not respond, and the length of benefit varies. A response cannot be guaranteed. Doctors use follow up visits and scans to assess how well treatment is working and whether the plan should change.
Because checkpoint inhibitors affect immune activity, they can sometimes cause the immune system to inflame healthy organs. Possible problems include inflammation of the lungs, bowel, liver, skin, or hormone producing glands. Side effects may be mild or serious, and some can appear during treatment or after it ends.
Tell the care team about new or worsening symptoms, even if they seem minor. Breathing difficulty, persistent diarrhea, severe abdominal pain, yellowing of the skin or eyes, or unusual weakness need prompt medical attention. Do not stop a prescribed treatment or start another medicine without discussing it with the care team.
How to discuss treatment choices with a specialist
Ask whether immunotherapy is appropriate for the exact mesothelioma type and stage, and whether it would be used alone or with chemotherapy. The specialist can explain likely benefits and risks in the context of the person’s health, as well as how treatment response and side effects will be monitored.
Asbestos exposure is the main known cause of mesothelioma, according to established health guidance. A history of exposure can help doctors understand risk, but it does not determine which treatment will work. For anyone facing a diagnosis, an experienced cancer team can help weigh approved treatment, symptom care, and clinical trials as circumstances change.
Frequently Asked Questions
Does immunotherapy work for mesothelioma?
It can help some people, including by shrinking tumors or slowing their growth, but it does not work for everyone. The benefit and risks depend on the person and the cancer.
Does mesothelioma respond to immunotherapy?
Some mesotheliomas respond, while others do not. Response can vary by cancer type and individual factors, so doctors monitor treatment with follow up assessments and scans.